Skip to main content
SpringerLink
Log in

Récidive homolatérale des cancers du sein : quels traitements adjuvants systémiques ?

  • Chapter
Cancer du sein en situation métastatique

  • 213 Accesses

Résumé

Grâce au dépistage, le cancer du sein est détecté de plus en plus précocement avec comme corollaire des traitements de plus en plus conservateurs et un risque de rechute à distance moindre mais une augmentation des rechutes locales.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Hammer J, Track C, Seewald DH, Spiegl KJ et al. (2009) Local relapse after breast-conserving surgery and radiotherapy. Strahlenther Onkol 185: 431–437

    Article  PubMed  Google Scholar 

  2. Fredriksson I, Lieljegren G, Arnesson LG et al. (2002) Local recurrence in the breast after conservative surgery. A study of prognosis and prognostic factor in 391 women. Eur J Cancer 38: 1860–1870

    Article  PubMed  CAS  Google Scholar 

  3. Fowble B, Solin LJ, Schultz DJ et al. (1990) Breast recurrence following conservative surgery and radiation: pattern of ailure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 19: 833–842

    Article  PubMed  CAS  Google Scholar 

  4. Dakberg K, Liedberg A, Johansson U et al. (2003) Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence. Eur J Surg Oncol 29: 143–154

    Article  Google Scholar 

  5. Van Tienhoven G, Voogd AC, Peterse JL et al. (1999) Prognosis after treatment for loco-regional recurrence after mastectomy of breast conserving therapy in two randomised trails (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danisth Breast Cancer Cooperative Group Eur J Cancer 35: 32–38

    Article  PubMed  Google Scholar 

  6. Kurtz JM, Amalric R, Brandone H et al. (1989) Local recurrence after breast conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer 63: 1912–1917

    CAS  Google Scholar 

  7. Voogt AC, Van Oost FJ, Rutgers EJ et al. (2005) Long term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 41: 2637–2644

    Article  Google Scholar 

  8. Galper S, Blood E, Gelman R et al. (2005) Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys 61: 348–357

    Article  PubMed  Google Scholar 

  9. Shen J, Hunt KK, Mirza NQ et al. (2005) Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer 104: 479–490

    Article  PubMed  Google Scholar 

  10. Fodor J, Major T, Polgar C et al. (2008) Prognosis of patients with local recurrence after mastectomy or conservative surgery for early-stage invasive breast cancer. Breast 17: 302–308

    Article  PubMed  CAS  Google Scholar 

  11. Blanco G, Holli K, Heikkinen M et al. (1990) Prognostic factors in recurrent breast cancer: relationships to site to recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br J Cancer 62: 142–146

    Article  PubMed  CAS  Google Scholar 

  12. O’brien ME (2008) Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer. Anticancer Drugs 19: 1–7

    Article  PubMed  Google Scholar 

  13. Blum JL, Dees EC, Vukelja SJ et al. (2007) Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy. Clin Breast Cancer 7: 465–470

    Article  PubMed  CAS  Google Scholar 

  14. Estevez LG, Batista N, Sanchez-Rovira P et al. (2008) A phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes. Clin Breast Cancer 8: 149–154

    Article  PubMed  CAS  Google Scholar 

  15. Lechleider RJ, Kaminskas E, Jiang X et al. (2008) Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies. Clin Cancer Res 15: 4378–4384

    Article  Google Scholar 

  16. Geyer CE, Forster J, Lindquist D et al. (2006) Lapatinib plus capecitabine for Her 2-positive advanced breast cancer. N Engl J Med 355: 2733–2743

    Article  PubMed  CAS  Google Scholar 

  17. O’Shaughnessy J, Blackwell KL, Burstein H et al. (2008) A randomized study of lapatinib alone or in combination with trastuzumab Her2+ metastatic breast cancer progressing on trastuzumab therapy (abstract 1015). ASCO Annual Meeting

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Jean Godinot, 1, Avenue du General Koenig, BP 171, 51100, Reims

    H. Curé

Authors
  1. H. Curé
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France

About this chapter

Cite this chapter

Curé, H. (2010). Récidive homolatérale des cancers du sein : quels traitements adjuvants systémiques ?. In: Cancer du sein en situation métastatique. Springer, Paris. https://doi.org/10.1007/978-2-8178-0076-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0076-9_19

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0075-2

  • Online ISBN: 978-2-8178-0076-9

Publish with us

Policies and ethics

Search

Navigation